-
BioMarin makes its largest-ever transaction, paying $4.8B for fellow rare disease drugmaker Amicus
19 Dec 2025 18:29 GMT
… 28-year history.
In a merger of rare disease specialists, BioMarin … soon face competition from Ascendis Pharma';s TransCon CNP, which … of the year after the drugmaker gained Inozyme for $270 million …
-
Fierce Pharma Asia—Daiichi ADCs' 1st-line nod, trial deaths; Takeda's TYK2 trial win
19 Dec 2025 18:29 GMT
… clinical hold comes as the pharma partners said they were aiming … Alzheimer's med
Fosun Pharma is spending about $200 million … 53% stake in Green Valley Pharmaceuticals, aiming to revive the latter … to go public in reverse merger with Vyne (release)
12. …
-
Advanced Biological Laboratories Signs Non-Binding LOI for Proposed Reverse Merger with ProPhase Labs
19 Dec 2025 07:00 GMT
… regarding a proposed reverse merger transaction pursuant to which … Following completion of the merger, a newly established U … testing solutions.
- CDL Pharma provides clinical trial logistics … obligations of the post-merger entity.
Transaction Status
The …
-
<![CDATA[Pharmaceutical Executive Daily: Pfizer's Stock Drops Following 2026 Revenue Projections Release]]>
19 Dec 2025 00:25 GMT
… .
In today’s Pharmaceutical Executive Daily, Pfizer … new collaboration and merger activity highlights continued … downstream access considerations for pharmaceutical manufacturers.
In deal news … Thanks for listening to Pharmaceutical Executive Daily. For …
-
Dow, Nasdaq, S&P 500 open higher as investors focus on cooling inflation data, Trump Media merger update
18 Dec 2025 16:47 GMT
… the US economy.
Trump Media merger update
On Thursday, Trump Media … ), according to MarketWatch data.
Athira Pharma Inc., Paranovus Entertainment Technology Ltd … Inc, Werewolf Therapeutics Inc, Processa Pharmaceuticals Inc, Inno Holdings Inc., Mega …
-
Salarius Pharmaceuticals Announces Planned Corporate Name and Ticker Symbol Change to Decoy Therapeutics, Reflecting Strategic Pivot to Next-Generation Antiviral and Peptide-Conjugate Platform
18 Dec 2025 12:50 GMT
… (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX) … Therapeutics. “With the merger complete, we are now … strategic collaborations with big pharma, technology leaders, and … projected. Contact:
Salarius Pharmaceuticals
Rick Pierce, CEO
Pierce …
-
<![CDATA[Roundup: Harbor BioMed Announces Collaboration and License Agreement with Bristol Myers, Squibb, VYNE Therapeutics Enters Merger Agreement with Yarrow Bioscience ]]>
17 Dec 2025 23:47 GMT
Harbour BioMed entered into a global collaboration and license agreement with Bristol Myers Squibb, and VYNE Therapetuics revealed a merger agreement with Yarrow Bioscience.
Harbour BioMed announced it has entered a multi-year, global strategic …
-
RTW's Yarrow to go public in reverse merger with Vyne Therapeutics
17 Dec 2025 18:11 GMT
-
E.F. Hutton Advises on Strategic Merger Between Apimeds and MindWave, Aligning Biotech Growth with AI-Enabled Financial Innovation
17 Dec 2025 13:00 GMT
… the recently completed merger between Apimeds Pharmaceuticals US Inc. ( … and negotiation process. The merger gives the combined business … MindWave on this compelling merger – a deal that … capital solutions, cross-sector mergers, and innovative financing models …
-
VYNE Therapeutics and Yarrow Bioscience Announce Merger Agreement
17 Dec 2025 13:00 GMT
… by partner Changchun GeneScience Pharmaceutical Co., Ltd (“GenSci”) … (the “Merger”). Upon completion of the Merger, the combined … with the definitive merger agreement. The Merger has received … closing of the proposed Merger; expectations regarding the …
About
© 1995-2025